Imperva (IMPV) Stock Rating Upgraded by JPMorgan Chase & Co.

Imperva (NASDAQ:IMPV) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a note issued to investors on Thursday, MarketBeat.com reports.

A number of other research firms have also weighed in on IMPV. Oppenheimer lowered shares of Imperva from an “outperform” rating to a “market perform” rating and set a $70.00 price objective for the company. in a research note on Friday, July 27th. BidaskClub lowered shares of Imperva from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 23rd. Stephens raised their price objective on shares of Imperva from $61.00 to $67.00 and gave the company an “overweight” rating in a research note on Thursday, June 14th. DA Davidson lowered shares of Imperva from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $56.00 to $46.00 in a research note on Friday, July 27th. Finally, Monness Crespi & Hardt lowered shares of Imperva from a “buy” rating to a “neutral” rating and set a $52.00 price objective for the company. in a research note on Friday, July 27th. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $56.37.

Shares of Imperva stock opened at $55.36 on Thursday. The stock has a market capitalization of $1.61 billion, a P/E ratio of -197.71 and a beta of 1.72. Imperva has a 1 year low of $37.17 and a 1 year high of $57.65.

Imperva (NASDAQ:IMPV) last released its quarterly earnings data on Thursday, July 26th. The software maker reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.07. The business had revenue of $84.80 million during the quarter, compared to analyst estimates of $87.22 million. Imperva had a negative net margin of 8.59% and a negative return on equity of 6.92%. Imperva’s revenue was up 13.9% compared to the same quarter last year. During the same period last year, the business earned $0.24 EPS. On average, analysts anticipate that Imperva will post -1.15 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada boosted its holdings in shares of Imperva by 99.4% in the first quarter. Royal Bank of Canada now owns 2,794 shares of the software maker’s stock worth $122,000 after buying an additional 1,393 shares during the last quarter. Xact Kapitalforvaltning AB boosted its holdings in shares of Imperva by 38.0% in the second quarter. Xact Kapitalforvaltning AB now owns 6,537 shares of the software maker’s stock worth $315,000 after buying an additional 1,800 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Imperva by 276.2% in the first quarter. Russell Investments Group Ltd. now owns 2,588 shares of the software maker’s stock worth $112,000 after buying an additional 1,900 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Imperva by 6.6% in the second quarter. Rhumbline Advisers now owns 33,741 shares of the software maker’s stock worth $1,628,000 after buying an additional 2,078 shares during the last quarter. Finally, United Services Automobile Association boosted its holdings in shares of Imperva by 5.0% in the second quarter. United Services Automobile Association now owns 49,973 shares of the software maker’s stock worth $2,411,000 after buying an additional 2,400 shares during the last quarter. 99.99% of the stock is currently owned by hedge funds and other institutional investors.

About Imperva

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Further Reading: Marijuana Stocks

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply